LODH Immunology Fund

investment firm

About

The LODH Immunology Fund is a Swiss open-ended mutual fund managed by Lombard Odier Darier Hentsch & Cie, a Swiss private bank.

  • Geneva,Geneve,Switzerland

Details

Operating Status
Active
Investor Type
Investment Bank

The LODH Immunology Fund is a Swiss open-ended mutual fund managed by Lombard Odier Darier Hentsch & Cie, a Swiss private bank. Approximately 20% of the assets of the fund are invested in privately held biotech companies.

Investments

Number of Investments
Number of Lead Investments
6
1
LODH Immunology Fund has made 6 investments. Their most recent investment was on May 12, 2009, when NovImmune raised $54.80M.
Date Company Name
Round Money Raised Industry Lead Investor
May 12, 2009 NovImmune
Series Unknown $54.80M Biotechnology
Jun 1, 2006 NovImmune
Series B $46M Biotechnology
May 14, 2002 ESBATech
Series A Fr14.50M Biotechnology Yes
Sep 27, 2001 7TM Pharma
Series A $15M Biotechnology
Jun 13, 2000 Genmab
Series Unknown $40.50M Biotechnology

Exits

LODH Immunology Fund has had 2 exits. LODH Immunology Fund most notable exits include Genmab ,   ESBATech

Date Company Name Exit Type Industry
Jul 17, 2019 Genmab IPO Biotechnology Detail
Sep 13, 2009 ESBATech M&A Biotechnology Detail